Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms

[1] Kobari M(1999)Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management Arch Surg 134 1131-1136

[2] Egawa S(2000)Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct Am J Surg Pathol 24 1372-1377

[3] Shibuya K(2003)Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas Br J Surg 90 1244-1249

[4] Terris B(2006)International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17-32

[5] Ponsot P(2014)Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review J Gastrointest Surg 18 1350-1357

[6] Paye F(2012)International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Pancreatology 12 183-197

[7] Sugiyama M(2014)Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients Am J Surg 208 202-209

[8] Izumisato Y(2010)Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas J Clin Gastroenterol 44 e224-e229

[9] Abe N(2014)Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis Ann Surg 259 72-81

[10] Tanaka M(2014)International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative HPB (Oxford) 16 929-935

[1] Kobari M(1999)Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management Arch Surg 134 1131-1136

[2] Egawa S(2000)Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct Am J Surg Pathol 24 1372-1377

[3] Shibuya K(2003)Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas Br J Surg 90 1244-1249

[4] Terris B(2006)International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17-32

[5] Ponsot P(2014)Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review J Gastrointest Surg 18 1350-1357

[6] Paye F(2012)International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Pancreatology 12 183-197

[7] Sugiyama M(2014)Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients Am J Surg 208 202-209

[8] Izumisato Y(2010)Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas J Clin Gastroenterol 44 e224-e229

[9] Abe N(2014)Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis Ann Surg 259 72-81

[10] Tanaka M(2014)International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative HPB (Oxford) 16 929-935